HOOKIPA Pharma Inc. Operating Income Loss

• HOOKIPA Pharma Inc. showed an increase of +47.3% in Operating Income Loss from 2023 to 2024.
• This data is from HOOKIPA Pharma Inc.'s annual report (Form 10-K), filed with the SEC on February 28, 2025.
• XBRL data for this metric is available from 2017 to 2024 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2017 to 2024), HOOKIPA Pharma Inc.'s Operating Income Loss has declined by 263.5%.
• Historical annual values: Fiscal year 2024: -$51.46 million | Fiscal year 2023: -$97.69 million | Fiscal year 2022: -$73.16 million | Fiscal year 2021: -$81.67 million | Fiscal year 2020: -$53.29 million | Fiscal year 2019: -$51.09 million | Fiscal year 2018: -$21.18 million | Fiscal year 2017: -$14.16 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026